1. Home
  2. EXAS vs CSL Comparison

EXAS vs CSL Comparison

Compare EXAS & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$103.38

Market Cap

19.6B

Sector

Health Care

ML Signal

HOLD

Logo Carlisle Companies Incorporated

CSL

Carlisle Companies Incorporated

HOLD

Current Price

$406.67

Market Cap

17.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
CSL
Founded
1995
1917
Country
Employees
N/A
N/A
Industry
Medical Specialities
Specialty Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
19.6B
17.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EXAS
CSL
Price
$103.38
$406.67
Analyst Decision
Buy
Buy
Analyst Count
19
6
Target Price
$84.27
$386.67
AVG Volume (30 Days)
2.4M
559.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
1.08%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$19.40
$2.21
Revenue Next Year
$13.54
$4.25
P/E Ratio
N/A
$23.84
Revenue Growth
N/A
N/A
52 Week Low
$38.81
$293.43
52 Week High
$103.54
$435.92

Technical Indicators

Market Signals
Indicator
EXAS
CSL
Relative Strength Index (RSI) 69.20 69.16
Support Level $103.14 $401.37
Resistance Level $103.87 $432.91
Average True Range (ATR) 0.35 13.91
MACD -0.12 2.42
Stochastic Oscillator 72.08 73.09

Price Performance

Historical Comparison
EXAS
CSL

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.

Share on Social Networks: